Surrogate/Clinician Communication: The Family Inpatient Communication Survey
Surrogate/Clinician Communication: The Family Inpatient Communication Survey
批准号:
8480151
负责人:
Alexia Mary Torke
金额:
$32.81万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2017-06-30
关键词:
AdultAgeAgreementAnxietyAreaCaringClinicalClinical ResearchCommunicationCommunity HospitalsConflict (Psychology)ConsultDataDecision MakingDeliriumDementiaDistressDo Not Resuscitate OrderElderlyElementsEmotionalEthicsFaceFactor AnalysisFamilyFamily memberFutureGeriatricsGoalsHealth CommunicationHospice CareHospitalizationHospitalsInpatientsInterventionInterviewLength of StayMeasuresMedicalMedical StaffMental DepressionModelingNursesNursing EthicsOutcomePalliative CarePatient CarePatientsPhysiciansPopulationProcessPsychometricsPublic HospitalsRegretsRelative (related person)ReportingResearchResearch InfrastructureResearch PersonnelRoleSamplingSocial WorkersStressSurveysSymptomsTestingTheoretical modelTimeWorkWritingbasedemographicsdesignexperienceimprovedinstrumentloved onesmeetingsoutcome forecastpost-traumatic stresspreferenceprogramspublic health relevancesatisfactionsecondary outcomesuburbsurrogate decision makertherapy developmenttool
中文摘要
描述(由申请人提供):随着人口老龄化,越来越多的住院老年人将需要家庭成员和其他代理人的帮助来为他们做出医疗决定。有证据表明,临床医生和代孕母亲之间的沟通往往很差,代孕母亲的决策者在住院期间和住院后经历了高度的痛苦,患者有时得到的护理是无效的或不需要的。我们的研究小组提出,临床医生和代理人之间的沟通质量可以提高患者及其代理人的决策质量和结果。然而,我们不知道沟通的哪些因素对代孕母亲最重要,因此应该成为未来干预的重点,我们对沟通影响患者和代孕母亲结果的机制了解有限。为了更好地了解这些问题,我们需要一种高质量的工具来评估医院环境中代孕母亲/临床医生的沟通和决策。据我们所知,目前还没有一种经过良好验证的工具来实现这一目的。目前的R01提案将验证一种新的工具来测量医院环境中代理决策者和临床医生之间的沟通质量,并将检查该测量与决策质量、代理痛苦和患者结果之间的关系。这项名为“家庭住院病人沟通调查”的新措施,考察了我们在早期工作中发现的对决策特别重要的几个沟通要素,如情感支持和频繁沟通。我们起草了该仪器,并进行了专家评审和试点测试。拟议的R01研究将进行必要的下一步,与来自印第安纳波利斯地区3家不同医院的代理决策者验证该工具,包括城市公立医院,三级转诊中心,
英文摘要
DESCRIPTION (provided by applicant): As the population ages, a growing number of hospitalized older adults will require the assistance of family members and other surrogates to make medical decisions for them. There is evidence that communication between clinicians and surrogates is often poor, that surrogate decision makers experience high degrees of distress during and after hospitalization, and that patients sometimes receive care that is ineffective or unwanted. Our research group has proposed that the quality of communication between clinicians and surrogates improves both the quality of decision making and outcomes for both patients and their surrogates. However, we do not know which elements of communication are most important to the surrogates and should therefore be the focus of future intervention and we have a limited understanding of the mechanisms by which communication impacts outcomes for patients and surrogates. To gain a better understanding of these issues, we need a high quality instrument to assess surrogate/clinician communication and decision making in the hospital setting. To our knowledge, there is no well-validated instrument for this purpose. The current R01 proposal will validate a new instrument to measure the quality of communication between surrogate decision makers and clinicians in the hospital setting and will examine relationships between this measure and decision quality, surrogate distress and patient outcomes. This new measure, the Family Inpatient Communication Survey, examines several elements of communication that we have identified in our earlier work to be especially important for decision making, such as emotional support and frequent communication. We have drafted the instrument, conducted expert review and pilot tested it. The proposed R01 study will conduct the essential next step, validating the instrument with surrogate decision makers from 3 diverse hospitals in the Indianapolis area, including an urban public hospital, a tertiary referral center,
and a suburban community hospital. We will also administer other well-validated measures of decision quality, surrogate outcomes (such as distress and depression), and patient care outcomes and will examine the relationships between communication quality, decision making quality, and patient and surrogate outcomes. We have assembled a diverse group of investigators with expertise in geriatrics, ethics, nursing and psychometrics. The research team will be advised by a Clinician Advisory Panel, including ICU physicians, a social worker and a nurse, to advise on the implementation of the study in the clinical setting. Findings from the current research will be crucial in the development of an intervention to improve communication and decision making in the hospital. The long term goal of this research agenda is to improve the quality of decisions for hospitalized patients and to improve the distress of surrogates who must make difficult choices for patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POST Facilitation for Community Dwelling Older Adults with and without Dementia
-
批准号:10664868
-
项目类别:
-
资助金额:$53.67万
-
财政年份:2019
-
负责人:Alexia Mary Torke
-
依托单位:
POST Facilitation for Community Dwelling Older Adults with and without Dementia
-
批准号:10226901
-
项目类别:
-
资助金额:$66.77万
-
财政年份:2019
-
负责人:Alexia Mary Torke
-
依托单位:
POST Facilitation for Community Dwelling Older Adults with and without Dementia
-
批准号:10451751
-
项目类别:
-
资助金额:$66.34万
-
财政年份:2019
-
负责人:Alexia Mary Torke
-
依托单位:
Communication in the Hospital: Impact on Patients with Alzheimer's Disease and Other Causes of Cognitive Impairments and their Surrogate Decision Makers
-
批准号:10428607
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Understanding the needs and experiences of surrogate decision makers caring for SGM individuals with Alzheimer's Disease and Related Dementias.
-
批准号:9931904
-
项目类别:
-
资助金额:$9.95万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Communication in the Hospital: Impact on the Patient and Surrogate
-
批准号:9162147
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Communication in the Hospital: Impact on the Patient and Surrogate
-
批准号:9346009
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Communication in the Hospital: Impact on Patients with Alzheimer's Disease and Other Causes of Cognitive Impairments and their Surrogate Decision Makers
-
批准号:10214974
-
项目类别:
-
资助金额:$18.1万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Communication in the Hospital: Impact on Patients with Alzheimer's Disease and Other Causes of Cognitive Impairments and their Surrogate Decision Makers
-
批准号:10606575
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2016
-
负责人:Alexia Mary Torke
-
依托单位:
Improving Surrogate/Clinician Communication: Validation of the Family Inpatient C
-
批准号:8681292
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2013
-
负责人:Alexia Mary Torke
-
依托单位:
Improving Surrogate/Clinician Communication: Validation of the Family Inpatient C
-
批准号:8867981
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2013
-
负责人:Alexia Mary Torke
-
依托单位:
Surrogate Decision Making for Hospitalized Older Adults
-
批准号:8122129
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2009
-
负责人:Alexia Mary Torke
-
依托单位:
Surrogate Decision Making for Hospitalized Older Adults
-
批准号:7739680
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2009
-
负责人:Alexia Mary Torke
-
依托单位:
Surrogate Decision Making for Hospitalized Older Adults
-
批准号:8531093
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2009
-
负责人:Alexia Mary Torke
-
依托单位:
Surrogate Decision Making for Hospitalized Older Adults
-
批准号:8309975
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2009
-
负责人:Alexia Mary Torke
-
依托单位:
Surrogate Decision Making for Hospitalized Older Adults
-
批准号:7929886
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2009
-
负责人:Alexia Mary Torke
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: